NVIV: InVivo Enrolls Patient No. 3, Statistics Point To Evidence Of Clinical Benefit So Far.
its his first purchase in open market...he has started accumulating. Remember he has millions of shares already. So this is more sign of confidence than anything else. I bet he will buy more coming weeks.
Insider Transaction: $AVXL Automatic Purchase at $0.37 per share of 1000 shares by Officer Missling Christopher U on 2015-06-04.
just the start of the CEO buying up shares in his company ! This is great news.
wow you are grasping for anything..how does he know anything ? Is he the CEO's brother in law ?? Or he is one of the test patients in Austrialia ?
georgejj1 you are full of you know what..you are posting the same #$%$ on the other message board. You don't know anything. and stop posting irrelevant links to documents on the other board too.
KITE treats 1st patient for its phase 1/2...just treats, not cure ! Just for phase 1/2 ! and stock is up 10% at already multi billion valuations.
stock is such low valuation at under 30 mil, very positive news so far for 2 indications.